Legal & General Group Plc purchased a new position in shares of Maximus, Inc. (NYSE:MMS – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 83,488 shares of the health services provider’s stock, valued at approximately $4,488,000. Legal & General Group Plc owned 0.16% of Maximus as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Assenagon Asset Management S.A. purchased a new stake in Maximus during the second quarter worth approximately $1,719,000. Dimensional Fund Advisors LP lifted its holdings in shares of Maximus by 7.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock valued at $135,084,000 after acquiring an additional 141,362 shares in the last quarter. Reinhart Partners LLC. lifted its holdings in shares of Maximus by 131.8% during the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock valued at $106,575,000 after acquiring an additional 1,127,346 shares in the last quarter. Walleye Capital LLC purchased a new stake in Maximus during the 2nd quarter worth $20,645,000. Finally, Quantinno Capital Management LP increased its holdings in Maximus by 413.1% in the 1st quarter. Quantinno Capital Management LP now owns 76,181 shares of the health services provider’s stock valued at $4,883,000 after purchasing an additional 61,335 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Zacks Research downgraded shares of Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce”.
Maximus Trading Down 1.5%
NYSE:MMS opened at $57.56 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. Maximus, Inc. has a fifty-two week low of $52.73 and a fifty-two week high of $100.00. The stock’s 50-day moving average is $57.91 and its two-hundred day moving average is $63.01. The stock has a market cap of $3.01 billion, a PE ratio of 8.50 and a beta of 0.59.
Maximus (NYSE:MMS – Get Free Report) last posted its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The company’s revenue was down 5.1% compared to the same quarter last year. During the same period in the previous year, the company earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, equities research analysts forecast that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.
Maximus Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were paid a $0.33 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. Maximus’s dividend payout ratio is currently 19.50%.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Further Reading
- Five stocks we like better than Maximus
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
